Ceiling-mounted high-field intraoperative MRI provides improved results
and patient outcomes
MINNEAPOLIS, May 20, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced that Barnes-Jewish Hospital
in St. Louis is the first U.S. hospital to use VISIUS® iMRI for more than 1,000 procedures. This clinical experience and
published evidence by the neurosurgical team has shown that
intraoperative MRI is an effective tool for improving results and
outcomes for patients undergoing brain surgery.
"Using MR during procedures instead of after, we can truly measure what
we have accomplished and go back and resect more tumor before actually
completing the surgery. We cannot see this tumor without iMRI. Our
published experience has shown this leads to better long-term survival
and quality of life," said Dr. Michael Chicoine, Barnes-Jewish
neurosurgeon and associate professor of neurological surgery at
Washington University School of Medicine. "While the iMR is among the
tools we use, the patients are the real beneficiaries as we limit the
risks for returning to surgery."
Installed in 2008, the VISIUS Surgical Theatre at Barnes Jewish Hospital
is a three-room suite where a high-field MR travels between two hybrid
operating rooms using ceiling-mounted rails with a third room in the
middle for storing the scanner when not in use. The high-quality MR
imaging provides surgeons with on-demand access to real-time updated
image detail during the procedures without moving the patient.
IMRIS CEO and President Jay D. Miller noted, "This milestone sets the
neurosurgical team at Barnes-Jewish and Washington University apart in
their pioneering leadership and experience. Their expertise and that of
other VISIUS installations is moving iMR towards the standard of care
for certain tumors and greater utilization for other neurosurgical
IMRIS supports ongoing studies and research regarding the use and
benefits of ceiling-mounted iMRI through an expanding Washington
University School of Medicine multicenter neurosurgical database called
I-MiND (IMRIS Multicenter iMRI Neurosurgery Database) which includes a
growing number of leading hospitals. IMRIS also produces proprietary
head fixation devices, imaging coils, and OR tables for use in this
unique and multifunctional intraoperative environment.
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. The multi-room suites
incorporate diagnostic quality high-field MR, CT and angio modalities
accessed effortlessly in the operating room setting. VISIUS Surgical
Theatres serve the neurosurgical, spinal, cardiovascular and
cerebrovascular markets and have been selected by 57 leading medical
institutions around the world.
SOURCE: IMRIS Inc.
For further information:
Kevin J. Berger
Marketing Communications Manager